vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Solana Co (HSDT). Click either name above to swap in a different company.

Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $5.2M, roughly 1.8× Solana Co). Solana Co runs the higher net margin — 6227.1% vs -234.3%, a 6461.3% gap on every dollar of revenue. On growth, Solana Co posted the faster year-over-year revenue change (2725.9% vs 223.8%). Over the past eight quarters, Solana Co's revenue compounded faster (522.3% CAGR vs 35.3%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

Solana is a Mexican cottage manufacturer of sports, racing, and kids' automobiles based in Mexico City. The family run company has operated since 1936, with a total production of fewer than fifty cars; the majority of them one-offs. The family is heavily involved in motor sports; the most prominent member was Moisés Solana, who raced family-built cars and later in Formula One.

FHTX vs HSDT — Head-to-Head

Bigger by revenue
FHTX
FHTX
1.8× larger
FHTX
$9.2M
$5.2M
HSDT
Growing faster (revenue YoY)
HSDT
HSDT
+2502.2% gap
HSDT
2725.9%
223.8%
FHTX
Higher net margin
HSDT
HSDT
6461.3% more per $
HSDT
6227.1%
-234.3%
FHTX
Faster 2-yr revenue CAGR
HSDT
HSDT
Annualised
HSDT
522.3%
35.3%
FHTX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FHTX
FHTX
HSDT
HSDT
Revenue
$9.2M
$5.2M
Net Profit
$-21.7M
$325.6M
Gross Margin
96.6%
Operating Margin
-258.2%
-3845.8%
Net Margin
-234.3%
6227.1%
Revenue YoY
223.8%
2725.9%
Net Profit YoY
-11.1%
8388.0%
EPS (diluted)
$-0.35
$111.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
HSDT
HSDT
Q4 25
$9.2M
$5.2M
Q3 25
$8.2M
$697.0K
Q2 25
$7.6M
$43.0K
Q1 25
$6.0M
$49.0K
Q4 24
$2.9M
$185.0K
Q3 24
$7.8M
$51.0K
Q2 24
$6.9M
$182.0K
Q1 24
$5.0M
$135.0K
Net Profit
FHTX
FHTX
HSDT
HSDT
Q4 25
$-21.7M
$325.6M
Q3 25
$-15.8M
$-352.8M
Q2 25
$-17.9M
$-9.8M
Q1 25
$-18.8M
$-3.8M
Q4 24
$-19.5M
Q3 24
$-19.1M
$-3.7M
Q2 24
$-23.0M
$-1.6M
Q1 24
$-25.0M
$-2.5M
Gross Margin
FHTX
FHTX
HSDT
HSDT
Q4 25
96.6%
Q3 25
85.2%
Q2 25
Q1 25
Q4 24
16.8%
Q3 24
Q2 24
35.2%
Q1 24
8.9%
Operating Margin
FHTX
FHTX
HSDT
HSDT
Q4 25
-258.2%
-3845.8%
Q3 25
-226.9%
-5086.1%
Q2 25
-279.2%
-7725.6%
Q1 25
-385.0%
-8185.7%
Q4 24
-840.5%
Q3 24
-305.5%
-7980.4%
Q2 24
-386.6%
-1796.7%
Q1 24
-558.3%
-2530.4%
Net Margin
FHTX
FHTX
HSDT
HSDT
Q4 25
-234.3%
6227.1%
Q3 25
-194.4%
-50612.3%
Q2 25
-237.3%
-22867.4%
Q1 25
-316.4%
-7832.7%
Q4 24
-682.9%
Q3 24
-244.9%
-7227.5%
Q2 24
-333.6%
-885.7%
Q1 24
-495.4%
-1863.7%
EPS (diluted)
FHTX
FHTX
HSDT
HSDT
Q4 25
$-0.35
$111.28
Q3 25
$-0.25
$-32.89
Q2 25
$-0.28
$-79.73
Q1 25
$-0.30
$-0.51
Q4 24
$-0.23
Q3 24
$-0.31
$-744.35
Q2 24
$-0.45
$-485.30
Q1 24
$-0.59
$-3.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
HSDT
HSDT
Cash + ST InvestmentsLiquidity on hand
$80.9M
$7.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-108.5M
$300.9M
Total Assets
$198.1M
$303.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
HSDT
HSDT
Q4 25
$80.9M
$7.3M
Q3 25
$89.3M
$124.1M
Q2 25
$72.6M
$6.1M
Q1 25
$61.0M
$1.1M
Q4 24
$55.5M
$1.1M
Q3 24
$57.7M
$3.5M
Q2 24
$138.9M
$6.4M
Q1 24
$79.3M
$3.6M
Stockholders' Equity
FHTX
FHTX
HSDT
HSDT
Q4 25
$-108.5M
$300.9M
Q3 25
$-89.7M
$-152.4M
Q2 25
$-76.7M
$6.0M
Q1 25
$-61.7M
$1.3M
Q4 24
$-45.5M
$1.1M
Q3 24
$-28.3M
$3.8M
Q2 24
$-14.3M
$6.3M
Q1 24
$-97.5M
$2.0M
Total Assets
FHTX
FHTX
HSDT
HSDT
Q4 25
$198.1M
$303.9M
Q3 25
$205.0M
$475.9M
Q2 25
$226.2M
$7.9M
Q1 25
$258.7M
$3.5M
Q4 24
$284.0M
$3.5M
Q3 24
$308.4M
$5.6M
Q2 24
$328.6M
$8.8M
Q1 24
$255.0M
$5.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
HSDT
HSDT
Operating Cash FlowLast quarter
$-22.3M
$-16.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.05×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
HSDT
HSDT
Q4 25
$-22.3M
$-16.5M
Q3 25
$-18.9M
$-4.0M
Q2 25
$-21.0M
$-2.8M
Q1 25
$-24.0M
$-3.5M
Q4 24
$-24.5M
$-11.0M
Q3 24
$-21.0M
$-2.8M
Q2 24
$-25.5M
$-2.9M
Q1 24
$-29.3M
$-3.0M
Free Cash Flow
FHTX
FHTX
HSDT
HSDT
Q4 25
Q3 25
Q2 25
$-21.0M
Q1 25
$-24.0M
Q4 24
$-25.0M
$-11.0M
Q3 24
$-21.3M
Q2 24
$-25.6M
Q1 24
$-29.4M
$-3.0M
FCF Margin
FHTX
FHTX
HSDT
HSDT
Q4 25
Q3 25
Q2 25
-278.2%
Q1 25
-403.2%
Q4 24
-875.3%
-5970.8%
Q3 24
-273.0%
Q2 24
-371.0%
Q1 24
-583.1%
-2226.7%
Capex Intensity
FHTX
FHTX
HSDT
HSDT
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.3%
Q1 25
0.5%
Q4 24
16.8%
2.7%
Q3 24
4.0%
0.0%
Q2 24
0.2%
0.0%
Q1 24
2.0%
3.7%
Cash Conversion
FHTX
FHTX
HSDT
HSDT
Q4 25
-0.05×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons